Aldeyra Therapeutics (ALDX) Tax Rate (2019 - 2020)
Aldeyra Therapeutics' (ALDX) quarterly Tax Rate came in at 4.07% in Q4 2020, up 415.0% YoY from 0.79% in Q1 2020, and up 5472.75% on a QoQ basis from 0.08% in Q4 2019.
Aldeyra Therapeutics (ALDX) Tax Rate (2019 - 2020) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 2 years of Tax Rate data on file, last reported at 4.07% in Q4 2020.
- Quarterly Tax Rate rose 415.0% year-over-year to 4.07% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 1.26% (down 83.0% YoY) and the FY2020 annual result came in at 1.26%, down 83.0% from the prior year.
- Tax Rate rose to 4.07% in Q4 2020, from 0.08% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 7.68% in Q1 2019 to a low of 0.08% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Aldeyra Therapeutics | 91.08 Mn | 91.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.07% |
| Dec 31, 2020 | 4.07% |
| Dec 31, 2020 | 4.07% |
| Dec 31, 2019 | -0.08% |
| Dec 31, 2019 | -0.08% |
| Dec 31, 2019 | -0.08% |
| Jun 30, 2019 | 0.07% |
| Jun 30, 2019 | 0.07% |
| Jun 30, 2019 | 0.07% |
| Mar 31, 2019 | 7.68% |
| Mar 31, 2019 | 7.68% |
| Mar 31, 2019 | 7.68% |